Literature DB >> 16475751

Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm.

Martin D Altschuler1, Timothy C Zhu, Jun Li, Stephen M Hahn.   

Abstract

The primary aim of this study was to determine whether optimized photodynamic therapy (PDT) treatment planning (seeking optimized positions, lengths, and strengths of the light sources to satisfy a given dose prescription) can improve dose coverage to the prostate and the sparing of critical organs relative to what can be achieved by the standard PDT plan. The Cimmino algorithm and search procedures based on that algorithm were tested for this purpose. A phase I motexafin lutetium (MLu)-mediated photodynamic therapy protocol is ongoing at the University of Pennsylvania. PDT for the prostate is performed with cylindrical diffusing fibers of various lengths inserted perpendicular to a base plate to obtain longitudinal coverage by a matrix of parallel catheters. The standard plan for the protocol uses sources of equal strength with equal spaced (1-cm) loading. Uniform optical properties were assumed. Our algorithms produce plans that cover the prostate and spare the urethra and rectum with less discrepancy from the dose prescription than the standard plan. The Cimmino feasibility algorithm is fast enough that changes to the treatment plan may be made in the operating room before and during PDT to optimize light delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16475751      PMCID: PMC4467800          DOI: 10.1118/1.2107047

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  23 in total

1.  Anatomy-based three-dimensional dose optimization in brachytherapy using multiobjective genetic algorithms.

Authors:  M Lahanas; D Baltas; N Zamboglou
Journal:  Med Phys       Date:  1999-09       Impact factor: 4.071

2.  Modeling the output ratio in air for megavoltage photon beams.

Authors:  T C Zhu; B E Bjärngard; Y Xiao; C J Yang
Journal:  Med Phys       Date:  2001-06       Impact factor: 4.071

3.  Optimization of brachytherapy dose distributions by simulated annealing.

Authors:  R S Sloboda
Journal:  Med Phys       Date:  1992 Jul-Aug       Impact factor: 4.071

4.  Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.

Authors:  S C Chang; G Buonaccorsi; A MacRobert; S G Bown
Journal:  Int J Cancer       Date:  1996-08-07       Impact factor: 7.396

5.  Expression of optical diffusion coefficient in high-absorption turbid media.

Authors:  T Nakai; G Nishimura; K Yamamoto; M Tamura
Journal:  Phys Med Biol       Date:  1997-12       Impact factor: 3.609

6.  Optimization of permanent 125I prostate implants using fast simulated annealing.

Authors:  J Pouliot; D Tremblay; J Roy; S Filice
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-10-01       Impact factor: 7.038

7.  Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.

Authors:  Timothy C Zhu; Andreea Dimofte; Jarod C Finlay; Diana Stripp; Theresa Busch; Jeremy Miles; Richard Whittington; S Bruce Malkowicz; Zelig Tochner; Eli Glatstein; Stephen M Hahn
Journal:  Photochem Photobiol       Date:  2005 Jan-Feb       Impact factor: 3.421

8.  Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.

Authors:  Timothy C Zhu; Jarod C Finlay; Stephen M Hahn
Journal:  J Photochem Photobiol B       Date:  2004-12-02       Impact factor: 6.252

9.  In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.

Authors:  Timothy C Zhu; Stephen M Hahn; Amy S Kapatkin; Andreea Dimofte; Carmen E Rodriguez; Teodor G Vulcan; Eli Glatstein; R Alex Hsi
Journal:  Photochem Photobiol       Date:  2003-01       Impact factor: 3.421

Review 10.  Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out.

Authors:  A V D'Amico; C N Coleman
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

View more
  19 in total

1.  Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostate.

Authors:  Augusto Rendon; J Christopher Beck; Lothar Lilge
Journal:  Phys Med Biol       Date:  2008-02-05       Impact factor: 3.609

Review 2.  The role of photodynamic therapy (PDT) physics.

Authors:  Timothy C Zhu; Jarod C Finlay
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

Review 3.  Photodynamic therapy for prostate cancer--a review of current status and future promise.

Authors:  Caroline M Moore; Doug Pendse; Mark Emberton
Journal:  Nat Clin Pract Urol       Date:  2009-01

4.  New Monte Carlo model of cylindrical diffusing fibers illustrates axially heterogeneous fluorescence detection: simulation and experimental validation.

Authors:  Timothy M Baran; Thomas H Foster
Journal:  J Biomed Opt       Date:  2011-08       Impact factor: 3.170

5.  Integrated light dosimetry system for prostate photodynamic therapy.

Authors:  Jun Li; Timothy C Zhu; Xiaodong Zhou; Dimofte Andreea; Jarod C Finlay
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2008-01-19

6.  A method to improve reconstruction of the distribution of hemoglobin, oxygenation, and MLu concentration in the human prostate before and after photodynamic therapy.

Authors:  Jarod C Finlay; Timothy C Zhu; Xiaodong Zhou; Andreea Dimofte; S B Malkowicz; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2007-02-27

7.  Surface markers for guiding cylindrical diffuser fiber insertion in interstitial photodynamic therapy of head and neck cancer.

Authors:  Emily Oakley; David A Bellnier; Alan Hutson; Brian Wrazen; Hassan Arshad; Harry Quon; Gal Shafirstein
Journal:  Lasers Surg Med       Date:  2017-02-10       Impact factor: 4.025

8.  A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.

Authors:  Timothy C Zhu; Martin D Altschuler; Yida Hu; Ken Wang; Jarod C Finlay; Andreea Dimofte; Keith Cengel; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2010-01

9.  Vascular targeted photodynamic therapy with TOOKAD® Soluble (WST11) in localized prostate cancer: efficiency of automatic pre-treatment planning.

Authors:  N Betrouni; S Boukris; F Benzaghou
Journal:  Lasers Med Sci       Date:  2017-06-01       Impact factor: 3.161

10.  A heterogeneous algorithm for PDT dose optimization for prostate.

Authors:  Martin D Altschuler; Timothy C Zhu; Yida Hu; Jarod C Finlay; Andreea Dimofte; Ken Wang; Jun Li; Keith Cengel; S B Malkowicz; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.